• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol . SARS-CoV-2 rapidly adapts in aged BALB/c mice and induces typical pneumonia

tetano

Editor, Senior Moderator
J Virol


. 2021 Mar 10;JVI.02477-20.
doi: 10.1128/JVI.02477-20. Online ahead of print.
SARS-CoV-2 rapidly adapts in aged BALB/c mice and induces typical pneumonia


Yufei Zhang[SUP] 1 2 3 [/SUP], Kun Huang[SUP] 1 2 3 [/SUP], Ting Wang[SUP] 1 2 3 [/SUP], Fei Deng[SUP] 4 [/SUP], Wenxiao Gong[SUP] 1 2 3 [/SUP], Xianfeng Hui[SUP] 1 2 3 [/SUP], Ya Zhao[SUP] 1 2 3 [/SUP], Xinlin He[SUP] 1 2 3 [/SUP], Chengfei Li[SUP] 1 2 3 [/SUP], Qiang Zhang[SUP] 1 2 3 [/SUP], Xi Chen[SUP] 2 [/SUP], Changjie Lv[SUP] 1 2 3 [/SUP], Xian Lin[SUP] 5 [/SUP], Ying Yang[SUP] 1 2 3 [/SUP], Xiaomei Sun[SUP] 1 2 3 [/SUP], Zhengli Shi[SUP] 5 [/SUP], Huanchun Chen[SUP] 1 2 [/SUP], Zhong Zou[SUP] 6 2 3 [/SUP], Meilin Jin[SUP] 6 2 3 [/SUP]



Affiliations

Abstract

Age is a risk factor for coronavirus disease 2019 (COVID-19) associated morbidity and mortality in humans; hence, in this study, we compared the course of severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection in young and aged BALB/c mice. We found that SARS-CoV-2 isolates replicated in the respiratory tracts of 12-month-old (aged) mice and caused pathological features of pneumonia upon intranasal infection. In contrast, rapid viral clearance was observed 5 days following infection in 2-month-old (young) mice with no evidence of pathological changes in the lungs. Infection with SARS-CoV-2 elicited significantly upregulated production of cytokines, especially interleukin 6 and interferon gamma, in aged mice; whereas this response was much weaker in young mice. Subsequent challenge of infected aged BALB/c mice with SARS-CoV-2 resulted in neutralized antibody responses, a significantly reduced viral burden in the lungs, and inflammation mitigation. Deep sequencing showed a panel of mutations potentially associated with the enhanced infection in aged BALB/c mice, such as the Q498H mutations which are located at the receptor binding domain (RBD) of the spike (S) protein. We further found that the isolates can not only multiply in the respiratory tract of mice but also cause disease in aged mice. Overall, viral replication and rapid adaption in aged BALB/c mice were associated with pneumonia, confirming that the age-related susceptibility to SARS-CoV-2 in mice resembled that in humans.ImportanceAged BALB/c model are in use as a model of disease caused by SARS-CoV-2. Our research demonstrated SARS-CoV-2 can rapidly adapt in aged BALB/c mice through causing mutations at the RBD of the S protein. Moreover, SARS-CoV-2-infected aged BALB/c mice indicated that alveolar damage, interstitial pneumonia, and inflammatory immune responses were similar to the clinical manifestations of human infections. Therefore, our aged BALB/c challenge model will be useful for further understanding the pathogenesis of SARS-CoV-2 and for testing vaccines and antiviral agents.
 
Back
Top Bottom